niacinamide has been researched along with Hepato-Pulmonary Syndrome in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib, a protein kinase inhibitor, is a systemic drug that has been licensed for the treatment of hepatocellular carcinoma (HCC)." | 9.16 | Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration. ( Bockisch, A; Ertle, J; Lauenstein, TC; Müller, S; Schlaak, JF; Schlosser, TW; Theysohn, JM, 2012) |
| "HPS (hepatopulmonary syndrome) is characterized by oxygen desaturation in patients with chronic liver disease." | 5.39 | Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. ( Chang, CC; Chuang, CL; Hsieh, HG; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS, 2013) |
| "Sorafenib, a protein kinase inhibitor, is a systemic drug that has been licensed for the treatment of hepatocellular carcinoma (HCC)." | 5.16 | Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration. ( Bockisch, A; Ertle, J; Lauenstein, TC; Müller, S; Schlaak, JF; Schlosser, TW; Theysohn, JM, 2012) |
| "HPS (hepatopulmonary syndrome) is characterized by oxygen desaturation in patients with chronic liver disease." | 1.39 | Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. ( Chang, CC; Chuang, CL; Hsieh, HG; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baweja, S | 1 |
| Kumari, A | 1 |
| Negi, P | 1 |
| Tomar, A | 1 |
| Tripathi, DM | 1 |
| Mourya, AK | 1 |
| Rastogi, A | 1 |
| Subudhi, PD | 1 |
| Thangariyal, S | 1 |
| Kumar, G | 1 |
| Kumar, J | 1 |
| Reddy, GS | 1 |
| Sood, AK | 1 |
| Vashistha, C | 1 |
| Sarohi, V | 1 |
| Bihari, C | 1 |
| Maiwall, R | 1 |
| Sarin, SK | 1 |
| Yang, W | 1 |
| Zhang, J | 1 |
| Hu, B | 1 |
| Wu, W | 1 |
| Venter, J | 1 |
| Alpini, G | 1 |
| Fallon, MB | 1 |
| Theysohn, JM | 1 |
| Schlaak, JF | 1 |
| Müller, S | 1 |
| Ertle, J | 1 |
| Schlosser, TW | 1 |
| Bockisch, A | 1 |
| Lauenstein, TC | 1 |
| Chang, CC | 1 |
| Chuang, CL | 1 |
| Lee, FY | 1 |
| Wang, SS | 1 |
| Lin, HC | 1 |
| Huang, HC | 1 |
| Teng, TH | 1 |
| Hsu, SJ | 1 |
| Hsieh, HG | 1 |
| Lee, SD | 1 |
1 trial available for niacinamide and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Female; Hepatopulmonary Syndrom | 2012 |
3 other studies available for niacinamide and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod.
Topics: Animals; Fingolimod Hydrochloride; Hepatopulmonary Syndrome; Inflammation; Liver Cirrhosis; Mice; Ni | 2023 |
The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
Topics: Animals; Common Bile Duct; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hepatopulmon | 2014 |
Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
Topics: Animals; Benzenesulfonates; Common Bile Duct; Disease Models, Animal; Hemodynamics; Hepatopulmonary | 2013 |